An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
Clinical trial NCT00444340 · COMPLETED
Trial details
- NCT number
- NCT00444340
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.